Advertisements do not influence the editorial decisions or content
Implications for employers: Employers are not likely to be able to purchase fully-insured health plans that cover anti-obesity GLP-1 medications at this point, unless the plans offer a rider where these medications are covered for an additional premium
Bikdeli B, Khairani C, Bejjani A, Lo Y, Mahajan S, Caraballo C, Jimenez J, Krishnathasan D, Zarghami M, Rashedi S, Jimenez D, Barco S, Secemsky E, Klok F, Hunsaker A, Aghayev A, Muriel A, Hussain M, Appah-Sampong A, Lu Y, Lin Z, Mojibian H, Aneja S, Khera R, Konstantinides S, Goldhaber S, Wang L, Zhou L, Monreal M, Piazza G, Krumholz H , Investigators P
Common questions people ask Whats the difference between Semaglutide and Tirzepatide